PTBP1 and cancer: Furthermore, the combination of PTBP1 with Linc‐ROR and miR‐124 can induce the resistance of cancer cells to gemcitabine (a chemotherapy drug), which may be achieved by activating survival signals or inhibiting the drug target pathway [77].